Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Genetics

The Biology and Genetics of AMC

At a Glance

Arthrogryposis Multiplex Congenita (AMC) is categorized into three main types: Amyoplasia, Distal Arthrogryposis, and Syndromic AMC. Identifying the exact cause through modern genetic testing helps predict a child's future needs, tailor effective treatments, and guide family planning.

While Arthrogryposis Multiplex Congenita (AMC) describes the physical finding of multiple stuck joints, the biology behind those joints varies greatly from one child to another. Pinpointing the specific “subtype” or genetic cause is a high priority for your medical team because it helps predict your child’s needs and provides a roadmap for their care [1][2].

The Three Main Categories

Doctors generally group AMC into three broad categories based on physical characteristics and underlying causes.

1. Amyoplasia (“Classic” AMC)

Amyoplasia is the most common form of AMC, accounting for about one-third of cases [3]. It is typically sporadic, meaning it is not inherited, and the risk of it happening again in a future pregnancy is extremely low (typically less than 1%) [4].

  • Physical Features: It often involves all four limbs. The classic posture includes shoulders turned inward, elbows straight, and wrists flexed. Feet are often severely turned in (clubfeet) [3].
  • Intelligence: Children with Amyoplasia almost always have normal to high intelligence [5][6].
  • Muscle: The term “amyoplasia” literally means “no muscle growth,” as fatty tissue often replaces some muscle during development [7].

2. Distal Arthrogryposis (DA)

DA refers to a group of genetic conditions that primarily affect the distal joints—those furthest from the center of the body, like the hands and feet [8].

  • Physical Features: Contractures are most visible in the fingers and toes. A common example is Freeman-Sheldon Syndrome, which can also affect facial muscles, giving a “whistling” appearance [9].
  • Genetic Link: DA is usually caused by mutations in genes that help muscles contract, such as MYH3, TNNI2, or TNNT3 [8][10]. These are often inherited in a dominant pattern, though new (de novo) mutations are common [11].

3. Syndromic AMC

In syndromic forms, the joint contractures are just one part of a larger condition that may involve the brain, heart, or other organs [1]. These forms are highly variable and require careful coordination between many different specialists [12].

The Role of Genetics and “FARIS”

Modern medicine has shifted away from invasive tests like muscle biopsies. Instead, Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS)—which only requires a simple, painless blood draw or cheek swab—is now the “gold standard” for evaluating AMC [13].

  • WES/WGS: It is important to note that if your child has Amyoplasia, their genetic tests will come back negative. For Amyoplasia, genetic testing is used to rule out other conditions to confirm the clinical diagnosis. For other forms, these tests scan thousands of genes to find the specific “typo” causing the condition, such as mutations in the TTN (titin) gene [14][15].
  • Maternal fAChR Antibodies: Sometimes, AMC isn’t caused by the baby’s genes, but by the mother’s immune system. A mother may have antibodies that temporarily “turn off” the baby’s muscle receptors (fetal acetylcholine receptor) during pregnancy [16]. This is called Fetal Acetylcholine Receptor Inactivation Syndrome (FARIS). Please know that this is an unavoidable biological event. It is absolutely not caused by anything the mother did or did not do during pregnancy. Testing for these antibodies is vital because it can change how future pregnancies are managed [17].

Why an Exact Diagnosis Matters

Finding the specific cause—whether it is a mutation in the MYH3 gene or a case of Amyoplasia—is not just about giving the condition a name. It is crucial for:

  1. Prognosis: Knowing if the condition might affect the heart or lungs later in life [2].
  2. Family Planning: Understanding the recurrence risk for future pregnancies [1].
  3. Tailored Therapy: Choosing the most effective surgical or therapeutic interventions based on how similar cases have progressed [18].

Common questions in this guide

Is Arthrogryposis Multiplex Congenita (AMC) always inherited?
No, AMC is not always inherited. The most common form, Amyoplasia, is typically sporadic, meaning it happens by chance. The risk of Amyoplasia occurring again in a future pregnancy is usually less than 1%.
Why do doctors use Whole Exome Sequencing (WES) to diagnose AMC?
Whole Exome Sequencing (WES) is a genetic test that scans thousands of genes using a simple blood draw or cheek swab. It is considered the gold standard because it can pinpoint specific genetic mutations causing the condition, or rule out other syndromes to confirm an Amyoplasia diagnosis.
What is Fetal Acetylcholine Receptor Inactivation Syndrome (FARIS)?
FARIS occurs when a mother's immune system produces antibodies that temporarily turn off a baby's muscle receptors during pregnancy, which can cause joint contractures. This is an unavoidable biological event and is absolutely not caused by anything the mother did or did not do.
Why does getting an exact genetic diagnosis for my child's AMC matter?
An exact diagnosis helps doctors predict if the condition might eventually affect other organs, like the heart or lungs. It also helps tailor the most effective therapies for your child and provides important recurrence risk information for future family planning.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child's physical appearance suggest Amyoplasia, or is a genetic subtype like Distal Arthrogryposis more likely?
  2. 2.If my child is diagnosed with Amyoplasia, are genetic tests still required, and what exactly are we trying to rule out?
  3. 3.Has my child been tested for mutations in the TTN or MYH3 genes?
  4. 4.Should I be tested for fetal acetylcholine receptor (fAChR) antibodies, and how would that affect future pregnancies?
  5. 5.Are there any signs of involvement in other organs, such as the heart or brain, that suggest a syndromic form?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Arthrogryposis Multiplex Congenita.

    Langston S, Chu A

    Pediatric annals 2020; (49(7)):e299-e304 doi:10.3928/19382359-20200624-01.

    PMID: 32674167
  2. 2

    Postnatal Diagnostic Workup in Children With Arthrogryposis: A Series of 82 Patients.

    Chareyre J, Neuraz A, Badina A, et al.

    Journal of child neurology 2021; (36(12)):1071-1077 doi:10.1177/08830738211022972.

    PMID: 34410827
  3. 3

    Treatment of the Upper Extremity Contracture/Deformities.

    Oishi SN, Agranovich O, Pajardi GE, et al.

    Journal of pediatric orthopedics 2017; (37 Suppl 1()):S9-S15 doi:10.1097/BPO.0000000000001002.

    PMID: 28594687
  4. 4

    Genetics and Classifications.

    Hall JG, Kimber E, van Bosse HJP

    Journal of pediatric orthopedics 2017; (37 Suppl 1()):S4-S8 doi:10.1097/BPO.0000000000000997.

    PMID: 28594686
  5. 5

    Clinical and Genetic Findings in a Series of Eight Families with Arthrogryposis.

    Pollazzon M, Caraffi SG, Faccioli S, et al.

    Genes 2021; (13(1)) doi:10.3390/genes13010029.

    PMID: 35052370
  6. 6

    Long-term outcome for patients with arthrogryposis multiplex congenita.

    Dubousset J, Guillaumat M

    Journal of children's orthopaedics 2015; (9(6)):449-58 doi:10.1007/s11832-015-0692-6.

    PMID: 26499455
  7. 7

    Arthrogryposis multiplex congenita-an update.

    Møller-Madsen B

    Journal of children's orthopaedics 2015; (9(6)):425-6 doi:10.1007/s11832-015-0688-2.

    PMID: 26482521
  8. 8

    Developmental myosins: expression patterns and functional significance.

    Schiaffino S, Rossi AC, Smerdu V, et al.

    Skeletal muscle 2015; (5()):22 doi:10.1186/s13395-015-0046-6.

    PMID: 26180627
  9. 9

    Biallelic Pathogenic Variants in TNNT3 Associated With Congenital Myopathy.

    Calame DG, Fatih J, Herman I, et al.

    Neurology. Genetics 2021; (7(3)):e589 doi:10.1212/NXG.0000000000000589.

    PMID: 33977145
  10. 10

    The distal arthrogryposis-linked p.R63C variant promotes the stability and nuclear accumulation of TNNT3.

    Lu J, Li H, Zhang H, et al.

    Journal of clinical laboratory analysis 2021; (35(12)):e24089 doi:10.1002/jcla.24089.

    PMID: 34766372
  11. 11

    Bi-allelic variants in MYH3 cause recessively-inherited arthrogryposis.

    Morali B, Miranda V, Raelson J, et al.

    Clinical genetics 2024; (106(4)):483-487 doi:10.1111/cge.14570.

    PMID: 38856159
  12. 12

    Collaborating to advance interdisciplinary care for individuals with arthrogryposis.

    Dahan-Oliel N, Hall JG

    American journal of medical genetics. Part C, Seminars in medical genetics 2019; (181(3)):273-276 doi:10.1002/ajmg.c.31741.

    PMID: 31471949
  13. 13

    The diagnostic workup in a patient with AMC: Overview of the clinical evaluation and paraclinical analyses with review of the literature.

    Dieterich K, Le Tanno P, Kimber E, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2019; (181(3)):337-344 doi:10.1002/ajmg.c.31730.

    PMID: 31368648
  14. 14

    The evolving genetic landscape of neuromuscular fetal akinesias.

    Haliloğlu G, Ravenscroft G

    Journal of neuromuscular diseases 2025; (12(5)):577-593 doi:10.1177/22143602251339357.

    PMID: 40356365
  15. 15

    Biallelic truncating TTN variants in M-band encoding exons cause a fetal lethal titinopathy.

    Li MW, Li F, Cheng ZX, et al.

    Prenatal diagnosis 2024; (44(1)):81-87 doi:10.1002/pd.6491.

    PMID: 38148006
  16. 16

    The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD).

    Allen NM, O'Rahelly M, Eymard B, et al.

    Brain : a journal of neurology 2023; (146(10)):4233-4246 doi:10.1093/brain/awad153.

    PMID: 37186601
  17. 17

    Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case report.

    Verlohren S, Dame C, Mayer B, et al.

    Neuromuscular disorders : NMD 2026; (60()):106354 doi:10.1016/j.nmd.2026.106354.

    PMID: 41650630
  18. 18

    Characterization of a group unrelated patients with arthrogryposis multiplex congenita.

    Valdés-Flores M, Casas-Avila L, Hernández-Zamora E, et al.

    Jornal de pediatria 2016; (92(1)):58-64.

    PMID: 26453511

This page provides educational information on the genetics and biology of Arthrogryposis Multiplex Congenita. Always consult a pediatric geneticist or specialist for personalized diagnoses and testing decisions.

Get notified when new evidence is published on Arthrogryposis multiplex congenita.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.